Trained in family medicine and pain management as well as complementary medical approaches such as traditional Chinese medicine and homeopathy, Dr. Berman has dedicated his career to evaluating the efficacy, safety and cost-effectiveness of complementary and integrative medicine. In 1991 he founded the first U.S. academic medical center-based program for integrative medicine.
Dr. Berman is one of the most highly funded National Institutes of Health (NIH) researchers in the area of integrative and complementary medicine. His grant funding has totaled more than $30 million over the past two decades and includes large clinical trials as well as NIH specialized center grants for the study of traditional Chinese medicine irritable bowel syndrome, arthritis and pain. These center grants have built collaborations with leading academic institutions in Hong Kong, China, Australia and the United States. In 2004, Dr. Berman’s landmark study showing acupuncture to be a safe and effective therapy for osteoarthritis of the knee was published as the lead article in the Annals of Internal Medicine.
His research publications include three books and more than 250 articles in leading medical journals focused on traditional Chinese therapies, such as acupuncture, herbs and qi gong, mind/body therapies, and integrative medicine approaches for a wide range of chronic health disorders. Many of his publications involve systematic reviews in integrative medicine and clinical trials in integrative medicine and pain management.
A pioneer in the field of integrative medicine, Dr. Berman was honored with the prestigious Bravewell Leadership Award for Integrative Medicine in 2005. The award “celebrates and supports visionaries who have committed their medical careers to transforming healthcare in America and ushering in a new practice of medicine.” He was chair of the ad hoc advisory committee to the NIH Office of Alternative Medicine when it opened in 1992, as well as the report to the NIH on alternative medicine. He currently serves on the advisory committee of NIH’s National Center for Complementary and Alternative Medicine.